Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer
PR Newswire•13/10/2026•07:00 ET
0
Key Highlights
- ➤Pulsenmore appoints David Woods as chief commercial officer.
- ➤U.S. commercial team expanded to accelerate growth following FDA De Novo authorization.
- ➤Company launched U.S. commercial operations and partnered strategically with Ouma Health.
- ➤Pulsenmore is exploring opportunities tied to the federal Rural Health Transformation Program.
Expert Statements
Elazar Sonnenschein, CEO and founder of Pulsenmore
“We believe the U.S. market presents a significant opportunity for Pulsenmore, with growing recognition of the need to bring maternal care closer to patients.”
Elazar Sonnenschein, CEO and founder of Pulsenmore
“Our commercial progress, together with new investments in rural healthcare, reinforces our commitment to this market. Expanding our commercial team and bringing David on board reflect our focus on translating this opportunity into sustainable growth.”
David Woods, Incoming Chief Commercial Officer of Pulsenmore
“I'm excited to join Pulsenmore and support its commitment to advancing women's health.”
David Woods, Incoming Chief Commercial Officer of Pulsenmore
“Bringing ultrasound into the home has the potential to make maternal care more accessible and connected, helping women feel informed and supported throughout their pregnancies.”
David Woods, Incoming Chief Commercial Officer of Pulsenmore
“I look forward to contributing my experience to help expand that impact.”
Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer PR Newswire
Expanded commercial team to accelerate U.S. growth as demand for accessible prenatal care and federal rural health investments create new opportunities
Get started
Create a free account to read the full story.